Algenist
NDC 53407-138, Octinoxate, Titanium Dioxide, Zinc Oxide, cream, from Solazyme, Inc..
- Product NDC
- 53407-138
- Status
- Listed
- Labeler
- Solazyme, Inc.
- Dosage form
- CREAM
- Route
- TOPICAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M020
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/53407-138 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OCTINOXATE75 mg/mL
- TITANIUM DIOXIDE20 mg/mL
- ZINC OXIDE171 mg/mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 53407-138-30 | 53407013830 | 1 CARTON in 1 BOX (53407-138-30) / 1 JAR in 1 CARTON / 30 mL in 1 JAR |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 53407-138 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/53407-138 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 53407-138. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.